455 related articles for article (PubMed ID: 16999760)
1. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation.
Everts PA; Hoffmann J; Weibrich G; Mahoney CB; Schönberger JP; van Zundert A; Knape JT
Transfus Med; 2006 Oct; 16(5):363-8. PubMed ID: 16999760
[TBL] [Abstract][Full Text] [Related]
2. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release.
Everts PA; Brown Mahoney C; Hoffmann JJ; Schönberger JP; Box HA; van Zundert A; Knape JT
Growth Factors; 2006 Sep; 24(3):165-71. PubMed ID: 17079200
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report.
Weibrich G; Kleis WK; Hitzler WE; Hafner G
Int J Oral Maxillofac Implants; 2005; 20(1):118-23. PubMed ID: 15747683
[TBL] [Abstract][Full Text] [Related]
4. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it].
Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451
[TBL] [Abstract][Full Text] [Related]
5. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells.
Ogino Y; Ayukawa Y; Kukita T; Koyano K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):724-9. PubMed ID: 16731390
[TBL] [Abstract][Full Text] [Related]
6. Influence of ethanol on the release of growth factors in human blood-derived platelet gels.
Kuo YP; Lee YL; Tseng YH; Su CH; Burnouf T; Su CY
Biologicals; 2010 Jan; 38(1):120-7. PubMed ID: 19720546
[TBL] [Abstract][Full Text] [Related]
7. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system.
Weibrich G; Kleis WK; Hafner G
Int J Oral Maxillofac Implants; 2002; 17(2):184-90. PubMed ID: 11958400
[TBL] [Abstract][Full Text] [Related]
8. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration.
Dugrillon A; Eichler H; Kern S; Klüter H
Int J Oral Maxillofac Surg; 2002 Dec; 31(6):615-9. PubMed ID: 12521317
[TBL] [Abstract][Full Text] [Related]
9. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.
Sundman EA; Cole BJ; Fortier LA
Am J Sports Med; 2011 Oct; 39(10):2135-40. PubMed ID: 21846925
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
[TBL] [Abstract][Full Text] [Related]
11. Platelet gel for healing cutaneous chronic wounds.
Crovetti G; Martinelli G; Issi M; Barone M; Guizzardi M; Campanati B; Moroni M; Carabelli A
Transfus Apher Sci; 2004 Apr; 30(2):145-51. PubMed ID: 15062754
[TBL] [Abstract][Full Text] [Related]
12. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis.
Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R
Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946
[TBL] [Abstract][Full Text] [Related]
13. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation.
Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E
Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699
[TBL] [Abstract][Full Text] [Related]
14. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies.
Dohan Ehrenfest DM; de Peppo GM; Doglioli P; Sammartino G
Growth Factors; 2009 Feb; 27(1):63-9. PubMed ID: 19089687
[TBL] [Abstract][Full Text] [Related]
15. Composition and characteristics of an autologous thrombocyte gel.
Altmeppen J; Hansen E; Bonnländer GL; Horch RE; Jeschke MG
J Surg Res; 2004 Apr; 117(2):202-7. PubMed ID: 15047124
[TBL] [Abstract][Full Text] [Related]
16. Bioactivity and stability of endogenous fibrogenic factors in platelet-rich fibrin.
Lundquist R; Dziegiel MH; Agren MS
Wound Repair Regen; 2008; 16(3):356-63. PubMed ID: 18282265
[TBL] [Abstract][Full Text] [Related]
17. Effect of different bone substitutes on the concentration of growth factors in platelet-rich plasma.
Hee Soon Cho ; Park SY; Kim S; Sang Keun Bae ; Duk Seop Shin ; Ahn MW
J Biomater Appl; 2008 May; 22(6):545-57. PubMed ID: 18194993
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of the kinetics of growth factors release from platelet gel.
Su CY; Kuo YP; Nieh HL; Tseng YH; Burnouf T
Transfusion; 2008 Nov; 48(11):2414-20. PubMed ID: 18694465
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro.
He L; Lin Y; Hu X; Zhang Y; Wu H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov; 108(5):707-13. PubMed ID: 19836723
[TBL] [Abstract][Full Text] [Related]
20. Counting of platelet derived growth factor and transforming growth factor-beta in platelet-rich-plasma used in jaw bone regeneration.
Tonelli P; Mannelli D; Brancato L; Cinotti S; Morfini M
Minerva Stomatol; 2005; 54(1-2):23-34. PubMed ID: 15902060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
